Cite
HARVARD Citation
Can, A. et al. (2020). The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect. Stem cells translational medicine. pp. 1287-1302. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Can, A. et al. (2020). The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect. Stem cells translational medicine. pp. 1287-1302. [Online].